Monitor for any updates on CEO Richard Gelfond's health and return timeline. While this is a routine interim arrangement, prolonged absence could prompt longer-term succession considerations. Recent insider selling activity ($4.5M in 30 days) may warrant additional scrutiny.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 20 $35.95entry
- T+1 · 7mo ago −0.56%α +0.10% · $35.75
- T+5 · 7mo ago +3.25%α +2.34% · $37.12
- T+20 · 6mo ago −4.73%α −8.93% · $34.25
- T+60 · 4mo ago +9.15%α +2.37% · $39.24
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
IMAX Corporation appointed Chief Legal Officer Robert D. Lister as interim principal executive officer while CEO Richard Gelfond is on temporary medical leave. Gelfond is expected to resume his role on May 1, 2026. Lister will not receive additional compensation for this temporary assignment.
Key Facts
- CEO Richard Gelfond is on temporary medical leave, previously announced on March 30, 2026
- Robert D. Lister, Chief Legal Officer and Senior Executive Vice President, appointed interim principal executive officer effective April 16, 2026
- Lister will serve in this role until May 1, 2026, when Gelfond is expected to resume duties
- No additional compensation will be paid to Lister for the interim role
- No changes to other executive arrangements or plans were made in connection with this appointment
Financial Impact
No financial impact, interim appointment without additional compensation
Risk Factors
- Potential uncertainty regarding CEO Gelfond's health and long-term availability
- Leadership transition risk if the interim period extends beyond May 1, 2026
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-025752 |
| Document: 0001628280-26-025752-index-headers.html | 0001628280-26-025752 |
| Document: 0001628280-26-025752-index.html | 0001628280-26-025752 |
| Document: 0001628280-26-025752.txt | 0001628280-26-025752 |
Track record
10 reports on IMAX
2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +3.80% at T+20 after the Mar 10, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $47.76 Now $46.76 −2.09% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $47.06 Now $46.76 −0.63% settles Nov 23
- Nov 6, 202610d ago Institutional Cluster Mixed 3/10 Entry $48.84 to $46.76 Now $46.76 −4.26% ▼ −4.26% −2.57% vs SPY
- Nov 5, 202611d ago 8-K Bullish 7/10 Entry $48.13 to $47.89 Now $46.76 −2.85% ▼ −0.50% −3.79% vs SPY
- Aug 26, 202611w ago Insider Cluster Bearish 5/10 Entry $51.94 to $51.92 Now $46.76 +9.97% ▲ +0.04% +0.31% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 4/10 Entry $54.79 to $51.20 Now $46.76 −14.66% ▼ −6.55% −7.02% vs SPY
- Apr 30, 202628w ago 8-K Mixed 5/10 Entry $36.51 to $35.64 Now $46.76 +28.07% ▼ −2.38% −4.73% vs SPY
- Apr 17, 202630w ago 8-K Neutral 3/10 Viewing Entry $35.95 to $37.12 Now $46.76 +30.07% ▲ +3.25% +2.34% vs SPY
- Mar 10, 202636w ago Insider Cluster Bearish 7/10 Entry $39.71 to $39.05 Now $46.76 −17.75% ▲ +1.66% +0.76% vs SPY
- Feb 25, 202637w ago 8-K Bullish 8/10 Entry $41.77 to $40.46 Now $46.76 +11.95% ▼ −3.14% −2.01% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers